Company

Enalees

5 rue Henri Desbruères – Building 7
91030 EVRY Cedex – FRANCE
Phone: +33 (0)1 78 05 47 25
Email: contact@enalees.com

Laurent THIERY: President

Web Site >

#Health / Well-being #Diagnostics

Diagnostics
Animal health
Veterinary
Molecular biology
Rapid test

Field of Activity

Enalees conceives, develops and markets next-generation rapid molecular diagnosis tests for veterinarians, and furthermore screening tests for SARS-CoV-2.

BACKGROUND

Enalees was created in December of 2015.

The company joined Genopole and became Genopole-accredited in February 2016. After two years of research, Enalees commercialized its first tests, Epona, for veterinarians working with horses, and a year later it brought the Astéria line to market for veterinarians working with dogs. Enalees also developed a SARS-CoV-2 diagnostic test during the COVID-19 pandemic to detect the causative virus in humans, cats, and the environment.

DESCRIPTION OF THE PRODUCTS / SERVICES / TECHNOLOGY

The purpose of Enalees’ rapid tests is to diagnose a disease via a portable reader within 40 minutes with no need to send samples to a specialized laboratory.

Also, in 2021, Enalees will begin offering a freeze drying service to numerous businesses thanks to its new lyophilization platform located at Genopole.

CUSTOMER REFERENCES / COLLABORATIONS / HIGHLIGHTS

Financial support from Bpifrance and the Île-de-France Administrative Region
Accredited by the Hippolia competitiveness cluster
Partnership with Bertin Technologies for the BEC-SARS-CoV-2 tests
Upcoming launch of a lyophilization platform

Further information

15 staff members
Strengths:
Simple and rapid detection of pathogens in less than 40 minutes on a portable and affordable device. Energetic and innovative team.

Genopole’s Companies

#Diagnostics

In same field

CGenetix

CGenetix, is a medTech start-up developing in vitro medical diagnostic devices for the follow-up of transplant patients.

Discover

EndoGene.Bio

Research & development for an in vitro diagnostic tool for endometriosis

Discover

SafeInsight

SafeInsight seeks to provide a response to the growing concerns of consumers for the composition of the products they buy and accompanies manufacturers aiming to attentively circumscribe the problem of endocrine disruptors.

Discover

Floating Genes

Floating Genes develops diagnostic tools for use in liquid biopsies via the highly sensitive NGS detection of circulating tumor DNA.

Discover

Cell Environment

Cell Environment is a company focusing on DNA damage detection involving unique and repeated sequences such as telomere and centromere sequences.

Discover

Innovhem

Our mission is to improve the management of Red Blood Cell diseases and in particular Sickle Cell Disease

Discover

Integragen

IntegraGen’s mission is to translate molecular research to clinical practice through the identification of novel genetic biomarkers and the subsequent commercialization of molecular diagnostic tests based on these discoveries.

Discover

View all >

With the support from